Cargando…
Update on liver disease management during the pandemic of coronavirus disease 2019 (COVID-19): 2021 KASL guideline
Autores principales: | Cho, Ju-Yeon, Lee, Young-Sun, Kim, Soon Sun, Song, Do Seon, Lee, Jeong-Hoon, Kim, Ji Hoon |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
The Korean Association for the Study of the Liver
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8524065/ https://www.ncbi.nlm.nih.gov/pubmed/34530524 http://dx.doi.org/10.3350/cmh.2021.0293 |
Ejemplares similares
-
Management of liver diseases during the pandemic of coronavirus disease-19
por: Cho, Ju-Yeon, et al.
Publicado: (2020) -
KASL clinical practice guidelines: Management of nonalcoholic fatty liver disease
por: Kang, Seong Hee, et al.
Publicado: (2021) -
Coronavirus Disease 2019 State Guidelines on Elective Surgery: Considerations for Plastic and Reconstructive Surgeons
por: Sarac, Benjamin A., et al.
Publicado: (2020) -
2021 Japanese Guidelines for the Management of Moyamoya Disease: Guidelines from the Research Committee on Moyamoya Disease and Japan Stroke Society
por: FUJIMURA, Miki, et al.
Publicado: (2022) -
Development of a Laboratory-safe and Low-cost Detection Protocol for SARS-CoV-2 of the Coronavirus Disease 2019 (COVID-19)
por: Won, Joungha, et al.
Publicado: (2020)